Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
6(85.7%)
Phase 3
1(14.3%)
7Total
N/A(6)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT01485029Not ApplicableCompleted

Streptococcus Pneumoniae Nasopharyngeal Carriage

Role: lead

NCT01639586Not ApplicableCompleted

Comparison for the Patient With Alzheimer Disease the Impact of Three Different Groups of Patient Care

Role: lead

NCT01706757Not ApplicableUnknown

Assessment of Motivity in People Aged 65 to 86 Years

Role: lead

NCT00825448Not ApplicableUnknown

Alcohol Addiction and Otorhinolaryngology Cancer

Role: lead

NCT00822029Phase 3Terminated

Use of Oral Bisphosphonates in the Treatment of Osteoporosis of Non-walking Children With Cerebral Palsy

Role: lead

NCT01095718Not ApplicableUnknown

Comparison of 3 Learning Methods to Improve Independent Activities of Daily Living (IADLs) in Alzheimer Disease

Role: lead

NCT01073098Not ApplicableUnknown

Evaluation of Muscle StO2 as a Prognostic Factor After Out of Hospital Cardiac Arrest

Role: lead

All 7 trials loaded